Summary
Overview
Work History
Education
Skills
Certification
Accomplishments
Timeline
AccountManager
Engy Hassan

Engy Hassan

North Africa Affiliate Safety Representative & Egypt NQPPV
Egypt

Summary

Dynamic PV Affiliate Safety Representative for North Africa, with 8+ years of experience in pharmacovigilance across multiple roles and countries in the Middle East & Africa. Expert in leading affiliate safety operations, implementing risk management strategies, and coordinating cross-functional teams to resolve regional safety challenges. Trusted QPPV and proven team leader, known for building strong partnerships with health authorities and internal stakeholders, delivering exceptional communication, and consistently surpassing patient safety and quality benchmarks. Celebrated for achieving key targets, and driving outstanding service through dedicated leadership.

Overview

18
18
years of professional experience
1
1
Certification
3
3
Languages

Work History

North Africa Affilaite Safety Representative

AbbVie
Cairo
12.2024 - Current
  • Acts as the Affiliate’s lead for pharmacovigilance matters with the National Regulatory Agency and AbbVie PSEQ (Pharmacovigilance and Patient Safety, Epidemiology and Research & Development Quality Assurance) function.
  • Facilitated open communication channels between employees and management regarding safety concerns, promoting a transparent work environment.
  • Served as a trusted resource for colleagues on safety-related topics, addressing questions and concerns promptly and knowledgeably.
  • As People Leader: To provide strategic leadership to manage and support the Pharmacovigilance (PV) team in executing assigned responsibilities.
  • Oversight of the Pharmacovigilance System by maintains oversight of the performance of all activities that fulfil local and applicable regional PV regulations, including those performed by PSEQ Regional PV Teams and/or outsourced partners
  • Affiliate Lead and point of contact for affiliate PV audits and Regulatory Authority PV inspections, demonstrating understanding of the overall AbbVie PV system and how Global PV processes and PSEQ Regional PV Teams are set-up and structured, supporting the fulfilment of local legal requirements.

Egypt N-QPPV

AbbVie
06.2020 - Current
  • Act as Local safety responsible ( LSR) for Egypt
  • Act as a single PV contact point for the competent authority (ies) of Egypt 24 hrs basis and also a contact point for PV inspections
  • Have an overview of medicinal product safety profiles and any emerging safety concerns;
  • Oversight of the Creation and maintenance of the local PSMF/PSSF;
  • Maintain awareness of Pharmacovigilance regulatory requirements and developments;
  • Ensuring conduct of pharmacovigilance and submission of all pharmacovigilance- related documents in accordance with the legal requirements and Good Vigilance
  • Practices
  • Support MEA case managemnet team to fulfill the responsibility for the execution of all aspects of PV individual case safety reporting (ICSR) processing to ensure that all of AbbVie's statutory and ethical responsibilities are met.

MEA Benefit Risk & Therapeutic Specialist

AbbVie
Cairo
10.2021 - 11.2024
  • Middle East & Africa - MEA, Accountable for Pharmacovigilance and products safety in all MEA countries portfolio for both legacies Allergan and AbbVie products

Risk Management

  • Performs product-specific benefit-risk activities and support in overseeing the safety profile of Abbvie MEA medicinal products in clinical development and those authorized and marketed, including devices and combination products
  • Reviews global risk management plan (RMP) and advises on local impact.
  • Collaborates with BR & TA Lead in the preparation of affiliate risk management team (ARMT) Meetings when required. Create local implementation plan (LIP) and ensure timely completion.
  • Creates and review local RMP annex for assigned products.
  • Submission of Risk Management related documents to regulatory authority.
  • Tracks Risk Minimization Tool distribution and measures effectiveness when required.
  • Implementation of relevant LIP and accompanying additional risk minimization tools (RMz), when and where applicable.

Periodic Safety Reporting and Development Safety Reporting

  • Reviews periodic safety update reports (PSUR)/ drug safety update reports (DSUR) /Line listings and advise on local impact.
  • Prepares local PSUR annex when applicable.
  • Prepares cover letter and submits to Regulatory authority/Ethics Committees or Investigators when applicable.
  • Advises functional lead on aggregate report schedule updates

Product Safety Monitoring & Therapeutic Area

  • Develops a relevant knowledge of the therapeutic area (TA) - disease knowledge, product knowledge, the safety profile, the benefit risk information, and the therapeutic landscape.
  • Submission of significant safety issues to local regulatory agency.
  • Reviews of safety data collection requirements for research activities (i.e., investigator-initiated studies (IIS), non-interventional studies (NIS), collaborative studies etc.) when applicable.
  • Reviews of study protocol (Clinical & post marketing observational studies (PMOS), Registry summary report, Clinical Safety reports, investigator-initiated studies (IIS) outputs when applicable.
  • Builds strong partnerships and work collaboratively with stakeholders and other functions across the business, such as Regulatory Affairs, Medical Affairs, Brand Teams, as applicable.
  • Performs surveillance of Local Safety Information and communicates to affiliate medical director (AMD) and pharmacovigilance & patient safety (PPS) for escalation and evaluation.
  • Oversights & internal communication of product safety updates, local safety data trending and monitoring activities.

Case Management Specialist

AbbVie
Cairo
10.2021 - 12.2022

This role is responsible for the day-to-day ICSR activities related to:

  • Case Intake and Triage including seriousness check, Trilogy entry and case processer allocation.
  • Case submission to authorities including CT, etc.
  • Case QC.
  • Follow-up Process.
  • Case Processing & Archiving.
  • Quality Reviews with internal partners
  • Quality Control Check (QCC) with service providers.
  • Reconciliations
  • Metrics/Dashboard entry
  • Review the result of the Literature Surveillance and Quality Review

Egypt LSR, Julphar
06.2019 - 05.2020
  • Act as PV contact point with corresponding local authorities on 24-hour basis
  • Have an overview of medicinal product safety profiles and any emerging safety concerns;
  • Create and maintain PSMF/PSSF;
  • Maintain awareness of Pharmacovigilance regulatory requirements and developments;
  • Perform weekly scientific literature screening and report identified ADRs;
  • Identify, collect and report adverse events (ICSRs);
  • Conduct all internal required training as per training plan;
  • Create and adapt SOPs as required
  • Ensuring conduct of pharmacovigilance and submission of all pharmacovigilance- related documents in accordance with the legal requirements and Good Vigilance
  • Practices
  • Read and acknowledge all necessary company standard operating procedures (SOPs)

Deputy QPPV

Utopia Pharmaceutical Company
10.2017 - 05.2019
  • Establish, maintenance Pharmacovigilance system and interaction between it and product quality systems
  • Manage the interactions between the Pharmacovigilance and other departments
  • Perform the Pharmacovigilance system master file (PSMF) and ensure that the information contained in it is accurate and up-to-date
  • Establishing, assessing and implementing a risk management system and evaluating the file effectiveness of the risk minimization by preparation and submission of risk minimization plans (RMP) for all products
  • Collection, processing, management, validation quality control, follow up for missing information, coding, classification, duplicate detection and archiving of individual case safety reports (ICSRs)
  • Scheduling, preparation, submission and assessment of periodic bene t/ risk evaluation report (PBRER)
  • Communication about safety concerns between marketing authorization holders (MAH) and national medicines authorities, in particular, notifying changes to benefit- risk balance of the medical product.

Clinical Pharmacist

Tanta Chest Hospital
07.2011 - 03.2017
  • Work closely with medical and nursing staff to make sure hospital patients receive the best treatment, advising on the selection, dose and type of administration
  • Provide help and advice to patients in all aspects of their medicines
  • Developing clinical pharmacy programs according to policies and regulations
  • Reviewing records of patients to determine the appropriateness of medication therapy
  • Evaluating patients condition to ensure all issues are being treated.

Methodology & stability analyst

SIGMA Pharmaceuticals
03.2008 - 06.2010
  • Develop a method to test new chemical entities and impurities/degradations in the finished products
  • Prepare valid methods of analysis for required pharmaceutical products including finished product, API, and excipients
  • Analyze organic and inorganic compounds to determine chemical and physical properties
  • Co-ordinate with Quality control department to smoothly transfer the method to the
  • QC department
  • Follow up stability plan for R&D samples and production batches
  • Prepare the Stability protocol and stability reports
  • Analyze R&D trials to achieve Final formula for planed products.

Education

Eng.for Prof Purposes - Eng.for Prof Purposes (B1A) Spring 2019, Grade A- (excellent)

American University in Cairo(AUC)
Cairo
08.2017

Diploma of Higher Education - Clinical pharmacy

Tanta University
Cairo
06.2016

Bachelor of Science - Pharmacy

6-October University
Cairo
06.2007

Skills

Ability to work in a logical, systematic manner

Certification

Training certificate as a qualified person responsible for Pharmacovigilance (QPPV) on GVP by Arab Union of Manufacturers of Pharmaceutical and Medical Appliances BY Dr. AMR SAAD. PSMF; Pharmacovigilance System & their Quality; PV Inspection; PV Audit from ICSR, Management& reporting of ADR. Case narrative writing for ICSR. RMP & RMM PSUR/PBRER & ACO. Advanced Pharmacovigilance training Hands-on practice with PRAMA-Egypt; 17-18 October 2018, Cairo Marriott, Egypt. Pharmacovigilance course for QPPV/LSR with Julphar on 16 December 2019. Pharmacovigilance and Regulatory Affairs in MENA with CCI Francaise En Egypte and ClinGroup; 9th of January 2020 in Cairo, Egypt. Introduction to Pharmacovigilance by Uppsala Monitoring System(UMC) on

Accomplishments

  • Coordinated with the Medical Team in MEA and Russia to facilitate the launch requirements and to have a solid tool that could be used by all colleagues throughout all the launch phases of the products.
  • Recognized by management for all-for-one behaviors, leading to facilitating the process to all users.

Timeline

North Africa Affilaite Safety Representative

AbbVie
12.2024 - Current

Case Management Specialist

AbbVie
10.2021 - 12.2022

MEA Benefit Risk & Therapeutic Specialist

AbbVie
10.2021 - 11.2024

Egypt N-QPPV

AbbVie
06.2020 - Current

Egypt LSR, Julphar
06.2019 - 05.2020

Deputy QPPV

Utopia Pharmaceutical Company
10.2017 - 05.2019

Clinical Pharmacist

Tanta Chest Hospital
07.2011 - 03.2017

Methodology & stability analyst

SIGMA Pharmaceuticals
03.2008 - 06.2010

Eng.for Prof Purposes - Eng.for Prof Purposes (B1A) Spring 2019, Grade A- (excellent)

American University in Cairo(AUC)

Diploma of Higher Education - Clinical pharmacy

Tanta University

Bachelor of Science - Pharmacy

6-October University
Engy HassanNorth Africa Affiliate Safety Representative & Egypt NQPPV